
Please contact Dr. Cho's office for more information or to schedule a consultation.
For detailed information, please contact Dr. Cho's office.
All Other Third Party
Blue Cross Blue Shield of Massachusetts
Molina
View All Insurances
3181 SW Sam Jackson Park Rd
Portland, OR 97239
(503) 494-5856
Faculty Development Award, Shore Fellowship Program for Scholars in Me
Young Investigator Award, Pediatric Brain Tumor Foundation
Laurel MD-PhD Scholar, Oregon Medical Research Foundation
Biology Committee, Pediatric Brain Tumor Consortium
Philip R. Dodge Young Investigator Award, Child Neurology Society
Beirne Faculty Scholar in Pediatirc Neuro-oncology, Stanford Universi
Scholar, St. Baldrick's Foundation
Epigenetic targeting of Hedgehog pathway transcriptiol output through BET bromodomain inhibition.
ture medicine, 2014
Reduced H3K27me3 and D Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant
Cancer cell, 2013
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
TURE, 2012
Integrative Genomic Alysis of Medullobl
JOURL OF CLINICAL ONCOLOGY, 2011
alpha 5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth
ACTA NEUROPATHOLOGICA, 2014
Cytogenetic Prognostication Within Medulloblastoma Subgroups
JOURL OF CLINICAL ONCOLOGY, 2014
Genome Sequencing of SHH Medulloblastoma Predicts Genotype
CANCER CELL, 2014
Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct
Jourl of neuro-oncology, 2014
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma.
Clinical cancer research, 2014
Medulloblastoma Down Under 2013
ACTA NEUROPATHOLOGICA, 2014
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
Acta neuropathologica, 2013
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular alysis.
lancet oncology, 2013
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma.
Jourl of clinical oncology, 2013
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.
ture genetics, 2013
BAF complexes facilitate decatetion of D by topoisomerase IIa.
ture, 2013
Genomic alysis of diffuse pediatric low
Proceedings of the tiol Academy of Sciences of the United States of Am, 2013
Inhibition of TWIST1 Leads to Activation of Oncogene-Induced Senescence in Oncogene
MOLECULAR CANCER RESEARCH, 2013
Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 sigling
MOLECULAR CANCER, 2013
Activation of ?-catenin/TCF targets following loss of the tumor suppressor SNF5.
Oncogene
The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012
Medulloblastomics: the end of the beginning
TURE REVIEWS CANCER, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
TURE, 2012
Dissecting the genomic complexity underlying medulloblastoma
TURE, 2012
Epigenetic ictivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors
CELL CYCLE, 2012
Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras
PLOS GENETICS, 2012
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
ACTA NEUROPATHOLOGICA, 2012
Molecular subgroups of medulloblastoma
ACTA NEUROPATHOLOGICA, 2012
MicroR-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma
ACTA NEUROPATHOLOGICA, 2012
Pleiotropic effects of miR-183 similar to 96 similar to 182 converge to regulate cell survival
ACTA NEUROPATHOLOGICA, 2012
Molecular subgroups of medulloblastoma: the current consensus
ACTA NEUROPATHOLOGICA, 2012
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
ACTA NEUROPATHOLOGICA, 2012
Clol selection drives genetic divergence of metastatic medulloblastoma
TURE, 2012
An Animal Model of MYC-Driven Medulloblastoma
CANCER CELL, 2012
Expression of FoxM1 is required for the proliferation of medulloblastoma cells
Clinical cancer research, 2011
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
CANCER CELL, 2011
Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical
JOURL OF CLINICAL ONCOLOGY, 2011
Molecular fingerprints of medulloblastoma and their application to clinical practice
FUTURE ONCOLOGY, 2011
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
NEURO-ONCOLOGY, 2011
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences
TURE COMMUNICATIONS, 2011
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
TURE MEDICINE, 2010
Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma
NEURO-ONCOLOGY, 2010
Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
CANCER CELL, 2010
The landscape of somatic copy-number alteration across human cancers
TURE, 2010
MELATONIN DEFICIENCY AND DISRUPTED CIRCADIAN RHYTHMS IN PEDIATRIC SURVIVORS OF CRANIOPHARYNGIOMA
NEUROLOGY, 2009
Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability
MOLECULAR AND CELLULAR BIOLOGY, 2008